Skip to main content
Premium Trial:

Request an Annual Quote

UNC, Kerr Drug to Study PGx Program for Plavix

NEW YORK (GenomeWeb News) – Drug store chain Kerr Drug and the Eshelman School of Pharmacy at the University of North Carolina, Chapel Hill plan to investigate the feasibility of implementing a pharmacogenomic program at the community pharmacy level directed at Plavix (clopidogrel).

Under the six-month study announced today, the partners will jointly develop a protocol, evaluate physician and patients opinions, and research reimbursement challenges and regulatory requirements to such a program.

"Because pharmacists have unique expertise in medication use and are point-of-care service providers, they can play an important role in facilitating pharmacogenetic testing and more personalized health care,” Rebecca Chater, executive vice president of Kerr Health, said in a statement. "This study will examine just how that role can be implemented."

Participants in the study will be screened at the pharmacy, with results interpreted and reviewed by the prescribing physician and the pharmacist.

In 2010, the US Food and Drug Administration put a black-box warning on the antiplatelet drug Plavix saying the drug may not be effective for patients with certain variants of the CYP2C19 gene. FDA recommended a patient undergo genetic testing before being put on the drug.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.